Carisma Therapeutics Inc. (NASDAQ: CARM)
$1.31
+0.0500 ( +3.97% ) 420.3K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$1.31
Previous close
$1.26
Volume
420.3K
Market cap
$54.01M
Day range
$1.25 - $1.38
52 week range
$0.99 - $9.77
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Jul 09, 2024 |
8-k | 8K-related | 13 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
3 | Insider transactions | 2 | Jul 01, 2024 |
3 | Insider transactions | 2 | Jul 01, 2024 |
8-k | 8K-related | 13 | Jul 01, 2024 |
8-k | 8K-related | 15 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |